Matches in SemOpenAlex for { <https://semopenalex.org/work/W4327732832> ?p ?o ?g. }
- W4327732832 abstract "Background: Long Mu Qing Xin Mixture (LMQXM) has shown potentially positive effects in alleviating attention deficit hyperactivity disorder (ADHD); however, the action mechanism is still not fully understood. This study aimed to predict the potential mechanism of LMQXM for ADHD using network pharmacology and molecular docking, which were then validated using animal experiments. Methods: Network pharmacology and molecular docking techniques were used to predict the core targets and potential pathways of LMQXMQ for ADHD, and KEGG pathway enrichment analysis revealed the potential significance of dopamine (DA) and cyclic adenosine monophosphate (cAMP) signaling pathways. To verify the hypothesis, we conducted an animal experiment. In the animal experiment, the young spontaneously hypertensive rats (SHRs) were randomly divided into the model group (SHR), the methylphenidate hydrochloride group (MPH, 4.22 mg/kg), and 3 LMQXM groups (low-dose (LD) group, 5.28 ml/kg; medium-dose (MD) group, 10.56 ml/kg; and high-dose (HD) group, 21.12 ml/kg), and administered by gavage for 4 weeks; the WKY rats were set as the control group. The open field test and Morris water maze test were used to evaluate the behavioral performance of rats, high performance liquid chromatography mass spectrometry (LC-MS) was used to analyze DA levels in the prefrontal cortex (PFC) and striatum of rats, ELISA was used to detect cAMP concentrations in the PFC and striatum, and immunohistochemistry and qPCR were used to analyze positive cell expression and mRNA expression for indicators related to DA and cAMP pathways. Results: The results showed that beta-sitosterol, stigmasterol, rhynchophylline, baicalein, and formononetin might be key components of LMQXM for ADHD and that these components bind well to the core targets, DA receptors (DRD1 and DRD2). Furthermore, LMQXM might act through the DA and cAMP signaling pathways. In the animal experiment, we found that MPH and LMQXM-MD controlled hyperactivity and improved learning and memory in SHRs, while LMQXM-HD only controlled hyperactivity in SHRs; meanwhile, MPH and LMQXM-MD upregulated DA and cAMP levels, mean optical density (MOD) of cAMP, and MOD and mRNA expression of DRD1 and PKA in the prefrontal cortex (PFC) and striatum of SHRs, while LMQXM-LD and LMQXM-HD upregulated DA and cAMP levels in the striatum, MOD of cAMP in the PFC, and mRNA expression of PKA in the PFC. However, we did not find a significant regulatory effect of LMQXM on DRD2. Conclusion: To sum up, this study demonstrated that LMQXM may increase DA levels mainly by activating the cAMP/PKA signaling pathway through DRD1, thereby controlling the behavioral disorders of SHRs, which is most effective at moderate doses, and this may be a key mechanism for LMQXM in the treatment of ADHD." @default.
- W4327732832 created "2023-03-18" @default.
- W4327732832 creator A5015968273 @default.
- W4327732832 creator A5019750875 @default.
- W4327732832 creator A5037093795 @default.
- W4327732832 creator A5050801597 @default.
- W4327732832 creator A5054992093 @default.
- W4327732832 creator A5078479753 @default.
- W4327732832 date "2023-03-17" @default.
- W4327732832 modified "2023-10-04" @default.
- W4327732832 title "Network pharmacology, molecular docking, and experimental validation to explore the potential mechanism of Long Mu Qing Xin mixture for the treatment of attention deficit hyperactivity disorder" @default.
- W4327732832 cites W1552820890 @default.
- W4327732832 cites W1964607429 @default.
- W4327732832 cites W1965030220 @default.
- W4327732832 cites W1987617098 @default.
- W4327732832 cites W1988414934 @default.
- W4327732832 cites W1988786263 @default.
- W4327732832 cites W1998083782 @default.
- W4327732832 cites W2004570705 @default.
- W4327732832 cites W2027921616 @default.
- W4327732832 cites W2075329148 @default.
- W4327732832 cites W2085329742 @default.
- W4327732832 cites W2096173332 @default.
- W4327732832 cites W2124613981 @default.
- W4327732832 cites W2124674986 @default.
- W4327732832 cites W2137877778 @default.
- W4327732832 cites W2140189222 @default.
- W4327732832 cites W2170146596 @default.
- W4327732832 cites W2172758943 @default.
- W4327732832 cites W2442357878 @default.
- W4327732832 cites W2507599921 @default.
- W4327732832 cites W2588554135 @default.
- W4327732832 cites W2615233693 @default.
- W4327732832 cites W2737811290 @default.
- W4327732832 cites W2741723075 @default.
- W4327732832 cites W2747699571 @default.
- W4327732832 cites W2751584274 @default.
- W4327732832 cites W2765345712 @default.
- W4327732832 cites W2775641245 @default.
- W4327732832 cites W2791150509 @default.
- W4327732832 cites W2792403778 @default.
- W4327732832 cites W2794227021 @default.
- W4327732832 cites W2806559562 @default.
- W4327732832 cites W2808011097 @default.
- W4327732832 cites W2878804173 @default.
- W4327732832 cites W2888169867 @default.
- W4327732832 cites W2890075814 @default.
- W4327732832 cites W2902354024 @default.
- W4327732832 cites W2915534298 @default.
- W4327732832 cites W2917075888 @default.
- W4327732832 cites W2920475580 @default.
- W4327732832 cites W2928665623 @default.
- W4327732832 cites W2934368903 @default.
- W4327732832 cites W2946412700 @default.
- W4327732832 cites W2961794370 @default.
- W4327732832 cites W2968216424 @default.
- W4327732832 cites W2970534831 @default.
- W4327732832 cites W2983166786 @default.
- W4327732832 cites W2987928072 @default.
- W4327732832 cites W2987934639 @default.
- W4327732832 cites W3003952797 @default.
- W4327732832 cites W3006304377 @default.
- W4327732832 cites W3016986447 @default.
- W4327732832 cites W3036737730 @default.
- W4327732832 cites W3036949298 @default.
- W4327732832 cites W3078690673 @default.
- W4327732832 cites W3081593519 @default.
- W4327732832 cites W3087547769 @default.
- W4327732832 cites W3096820142 @default.
- W4327732832 cites W3097145107 @default.
- W4327732832 cites W3098935468 @default.
- W4327732832 cites W3106687433 @default.
- W4327732832 cites W3108977371 @default.
- W4327732832 cites W3112981210 @default.
- W4327732832 cites W3119793384 @default.
- W4327732832 cites W3120864103 @default.
- W4327732832 cites W3124902618 @default.
- W4327732832 cites W3124919258 @default.
- W4327732832 cites W3154550139 @default.
- W4327732832 cites W3160920105 @default.
- W4327732832 cites W3175198370 @default.
- W4327732832 cites W3181133224 @default.
- W4327732832 cites W3184002723 @default.
- W4327732832 cites W3206618060 @default.
- W4327732832 cites W3209698353 @default.
- W4327732832 cites W4211094461 @default.
- W4327732832 cites W4220847094 @default.
- W4327732832 cites W4225738430 @default.
- W4327732832 cites W4226257974 @default.
- W4327732832 cites W4229054631 @default.
- W4327732832 cites W4307711963 @default.
- W4327732832 doi "https://doi.org/10.3389/fphar.2023.1144907" @default.
- W4327732832 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37007045" @default.
- W4327732832 hasPublicationYear "2023" @default.
- W4327732832 type Work @default.
- W4327732832 citedByCount "0" @default.
- W4327732832 crossrefType "journal-article" @default.
- W4327732832 hasAuthorship W4327732832A5015968273 @default.
- W4327732832 hasAuthorship W4327732832A5019750875 @default.
- W4327732832 hasAuthorship W4327732832A5037093795 @default.